<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "IDArubicin inj VIAL">
<dose><value>8</value>
<value>10</value>
<value>12</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>1 mg/mL</value>
<value>10 mg</value>
<value>5 mg</value>
</strength>
<frequency><value>ONCE</value>
</frequency>
<instruction></instruction>
<volume><value>10 mL</value>
<value>5 mL</value>
</volume>
<units><value>mg/m2</value>
</units>
<Population><value>ADULT</value>
<value>CHILDREN</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>ALL, ANLL. Recommend 50% dose reduction in patients with serum creatinine greater than 200 umol/L. In patients with serum Bilirubin 40 to 85 umol/L, suggest 50% dose reduction. If serum bilirubin level is greater than 85 umol/L; suggest omit dose.</value>
<value>ALL. Recommend 50% dose reduction in patients with serum creatinine greater than 200 umol/L. In patients with serum Bilirubin 40 to 85 umol/L, suggest 50% dose reduction. If serum bilirubin level is greater than 85 umol/L; suggest omit dose.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3396</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3399</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3398</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>F</value>
</AHSFormularyStatus>
<HighAlert><value>HIGH ALERT MEDICATION</value>
</HighAlert>
</drug>